An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.
Dec 2, 2020
0
12
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men, according to new research published today in the American Heart Association's ...
Nov 30, 2020
1
32
Researchers have identified a new druggable target for heart failure in neonates and infants, a condition for which there has been no specific treatment. Approximately 60 percent of children born with congenital heart abnormalities ...
Nov 19, 2020
0
2
A novel patient engagement tool led one in five patients with heart failure to a more effective treatment regimen of generic medications, according to late-breaking research presented today at the American Heart Association's ...
Nov 17, 2020
0
2
The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking ...
Nov 17, 2020
0
4
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way. Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors ...
Nov 17, 2020
0
18
Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today ...
Nov 13, 2020
0
3
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from ...
Oct 8, 2020
0
21
Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. ...
Sep 28, 2020
0
11
People with chronic breathlessness enjoy getting back in the driver's seat when their symptoms are better controlled—with researchers finding that low-dose, extended release morphine capsules may help with this.
Aug 13, 2020
0
2
